Stock Track | 3D Systems Soars 5.19% as Subsidiary Systemic Bio Wins Prestigious SLAS Innovation Award

Stock Track
02-05

3D Systems Corporation (NYSE: DDD) saw its stock soar 5.19% in the pre-market trading session on Wednesday, driven by positive news surrounding its subsidiary, Systemic Bio.

Systemic Bio, a wholly-owned company of 3D Systems focused on accelerating drug discovery and development, has been named the winner of the prestigious SLAS 2025 Innovation Award. This award recognizes groundbreaking technological advancements poised to drive innovation in laboratory science and automation.

The award highlights Systemic Bio's proprietary h-VIOS™ platform, designed to accelerate drug discovery and development using bioprinted human tissues. The platform enables early identification of safety concerns, capturing risks that historically have only been discovered during clinical trials, even after non-human primate studies failed to flag such issues.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10